Compound for repairing eye diseases and aging extraction preparation method

By using a complex that undergoes supercritical extraction and three aging processes, the problems of high surgical risks and limited drug treatment for ophthalmic diseases have been solved, achieving effective non-surgical treatment for eye diseases such as myopia, pseudomyopia, and cataracts.

CN122097467APending Publication Date: 2026-05-29杨莉
0 Cites 0 Cited by

Patent Information

Application Number
CN202311085338.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-08-28
Publication Date
2026-05-29

AI Technical Summary

Technical Problem

In current treatments for eye diseases, surgical treatment carries significant risks, is prone to recurrence and is unstable, while drug treatment has limited effectiveness. In particular, there is a lack of effective non-surgical treatment options for children with myopia and elderly patients with cataracts.

Method used

Extracts of Senecio scandens, astaxanthin, Artemisia capillaris, Gardenia jasminoides, Lygodium japonicum, and Cassia tora were extracted using supercritical fluid extraction technology. After three aging processes, a complex was synthesized to form the Xinsenmai Compound Tianmu Complex, which is used for oral treatment of eye diseases.

Benefits of technology

This compound restores intraocular pressure and optic nerve without surgery or harm to the body, and can essentially cure eye diseases such as myopia, pseudomyopia, cataracts, and glaucoma, with a safe and side-effect-free therapeutic effect.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a compound for repairing eye diseases and an aging extraction preparation method. The compound is synthesized by extracting effective components of senecio scandens, astaxanthin, herba artemisiae scopariae, fructus gardeniae, lygodium japonicum and semen cassiae. The traditional Chinese medicine composition has a good treatment effect on eye diseases such as myopia, pseudomyopia, cataract, glaucoma and chloasma, intraocular pressure, optic nerves and intraocular pressure tubes are gradually improved by orally taking the extract, ocular axis refraction is basically recovered, and the purpose of basic curing is achieved; according to the invention, pure plants and traditional Chinese medicines are subjected to supercritical extraction to obtain an extract, the Cinsenmai compound temmoku compound is obtained by adopting a three-time reaction kettle induced aging technology, and the compound is safe, has no side effect and is an innovative modern novel traditional Chinese medicine technical product.
Need to check novelty before this filing date? Find Prior Art